kasus ggk 2.pdf
-
Upload
dewinoorjannah -
Category
Documents
-
view
218 -
download
4
description
Transcript of kasus ggk 2.pdf
![Page 1: kasus ggk 2.pdf](https://reader035.fdocuments.in/reader035/viewer/2022073018/563db872550346aa9a93c69e/html5/thumbnails/1.jpg)
Prodi S1 Farmasi Fakultas Farmasi Universitas Mulawarman
41
2. PATIENT DATABASE
Demographic and Administration Information
Name : Tn.SYN
Address : Jl. Gubeng Kertajaya I/45
Age : 45 th
Height : 161 cm Weight: 53 kg
Admission Date : 20 Mei 2014
Discharge : 30 Mei 2014
Patient ID : 10874141 Room No:R.Interna I/ C.14
MD : dr. T
Pharmacy : Kelompok IV
Race : Jawa Gender : laki-laki
Religion : Islam
Occupation : Buruh bangunan
![Page 2: kasus ggk 2.pdf](https://reader035.fdocuments.in/reader035/viewer/2022073018/563db872550346aa9a93c69e/html5/thumbnails/2.jpg)
Prodi S1 Farmasi Fakultas Farmasi Universitas Mulawarman
42
History of
Present Illness:
Sesak sejak 1
hari sebelum
MRS bila tidur
dalam posisi
terlentang,
pasien semakin
sesak. Bila tidur
bantal di
tinggikan,
batuk(-) panas(-
), mual (-)
muntah(-),lemas
(+). Bengkak
anggota gerak
atas bawah,
Vital Sign/Laboratory Data – Initial/Follow up
Date Normal 20/10 21/10 22/10 23/10 26/10 27/10 28/10
29/10
30/10
RR HR Temp BP Data Serum
Hb Leko Tromb Alb LED MCV MCH MCHC RBC HCT RDW PLT MPV GDA PH pCO2
pO2
HCO3
BE K Na
20x/menit 80x/menit
36,7-37,0˚C 120/80mmHg
11-18 g/dL
4,5-10,5×10³/μL 150-450x103/ μL
3,4-5,4 0-8 mm/jam
80-99 fL 27-31pg
33,37 g/dL 4,04-6,13 M/uL
37,7-53,7 % 11,6-14,8 %
142-424 K/uL 0-99,9 fL
<110 mg/dL
7.35-7,45 35-45 mmHg 80-107 mmHg 21-25 mEq/L
-3,5+2,0 mEq/L
3,8-5,0 mEq/L 136-144 mEq/L
28 106 36,8
190/100
8,6
17.200 265.000
2,7
3,05 24,4 15,4 295 9,5
188
7,448 24,9 48
17,1
4,17 110
32 104 37,1
180/90
6,86
13.200
2,73 24
14,5 299 14,1
235 7,41 38 83
20 88
37,2 140/90
89,5 25,1 28,0 2,59 23,2 14,5 285 13,8
7,41 38 53
24,1 -0,5
4,17
133,7
24 98
37,2 140/90
24 80
36,9 170/100
9,55
14.300
2,7
91,5 27,8 30,4 3,43 9,55 14,9 322 10,6
4,24
25 85
36,7 160/110
12,7
12.300
90
86,4 23,4 32,8 4,46 38,6 14,4 351 11,0
7,46 35 61
24,9 1,1
3,88
138,7
20
36,8 140/90
20 88
37,7 160/100
220
20 89 37
160/100
Past Medical
History/Surgery
:
DM,HT,HD 7x
![Page 3: kasus ggk 2.pdf](https://reader035.fdocuments.in/reader035/viewer/2022073018/563db872550346aa9a93c69e/html5/thumbnails/3.jpg)
Prodi S1 Farmasi Fakultas Farmasi Universitas Mulawarman
43
Family and
Social History :
Cl Eo Baso Batang Seg Limf Mono Bl.Dir Indir TTT SGOT SGPT BUN SCr ClCr
97-103 mEq/L
100-300/mm3 40-100/mm3
1700-3500/mm3 200-600/mm3
<25 U/L <29 U/L
10-20 mg/dL <1.1 mg/dL
179
16 11
61,1 6,9
10,15
104
11 8
32,2 4,2
16,56
129,4 101,3
520 213
10 7
58,6
109,1 232 195
3,5
Lifestyle: -
Diagnosa :
Diabetes
Mellitus
Nephrotic
Disease Stage V
(DM ND V)
![Page 4: kasus ggk 2.pdf](https://reader035.fdocuments.in/reader035/viewer/2022073018/563db872550346aa9a93c69e/html5/thumbnails/4.jpg)
Prodi S1 Farmasi Fakultas Farmasi Universitas Mulawarman
44
Current Drug Therapy
Drug
Name/Dose/Strength/Route Prescribed
Schedule
Duration Start –
Stop Dates
Compliance/Dosing
Issue
1. Furosemid injeksi 3x 1 iv
2. Amlodipin 10 mg po
3. Asam folat 3 x1 tab
4. CaCO3 3 x 1 tab
5. Albumin drip 20 %
6. Transfusi PRC 1 kolf/hr
7. Humulin R 3 x 4 U sc
8.OMZ 2 x 40 mg
Tiap 8 jam
Tiap 24 jam
Tiap 8 jam
Tiap 8 jam
Tiap 8 jam
Tiap 12 jam
20/10 - 28/10
20/10 – 28/10
21/10 – 28/10
21/10 – 28/10
22/10 – 27/10
22/10 – 26/10
22/10 - 28/10
23/10 – 28/10
Patuh
Patuh
Patuh
Patuh
Patuh
Patuh
Patuh
Patuh
Patuh
Bagaimana rencana pelayanan kefarmasian yang akan dilakukan?(menggunakan metode SOAP)
E. Daftar Pustaka
A. Daftar Pustaka
Medication PTA
Tidak ada
(Pasien lupa mendapat obat apa saja dan mengaku tidak pernah minum obat apapun sebelumnya)
![Page 5: kasus ggk 2.pdf](https://reader035.fdocuments.in/reader035/viewer/2022073018/563db872550346aa9a93c69e/html5/thumbnails/5.jpg)
Prodi S1 Farmasi Fakultas Farmasi Universitas Mulawarman
45
Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM. Pharmacotherapy A Pathophysiologic Approach. 7th ed.
New York: McGraw-Hill Companies; 2008.
KDIGO 2012 Clinical Practice Guideline for the Evalution and Management of Chronic Kidney Disease. Journal of The
International Society Nephrology. 2012; 3 (1).